Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Department of Biophysics and Radiation Biology, Semmelweis University, Budapest, Hungary.
Thromb Haemost. 2018 Aug;118(8):1397-1408. doi: 10.1055/s-0038-1661393. Epub 2018 Jul 4.
There is an unstable balance between pro- and anti-haemostatic processes in patients with cirrhosis. We hypothesized, that in patients with acute decompensation (AD) the major alterations of von Willebrand factor (VWF) could contribute to the pro-thrombotic situation as compared to patients with stable (ST) cirrhosis.
We analysed different parameters of VWF, including detailed multimer distribution by densitometry and platelet adhesion, together with isintegrin-like nd etalloproteinase with hrombopondin type-1 motifs (ADAMTS13) activity and antigen and C-reactive protein (CRP) levels in patients with ST cirrhosis ( = 99), with AD ( = 54) and controls ( = 92).
VWF antigen, ristocetin co-factor as well as collagen-binding activities were elevated in both cirrhotic groups in a stepwise manner. There was a decrease in high and an increase in low molecular weight multimer ratios in the majority of ST cirrhosis. However, in 24 out of 54 AD patients, ultra-large VWF multimers (ultra-large molecular weight multimers [ULMWM]) were found. ADAMTS13 activity in ST and AD patients without ULMWM was similar to controls (median [interquartile range; IQR]%: 98 [67-132] and 91 [60-110] vs. 106 [88-117], respectively). The presence of ULMWM in AD patients was associated with low ADAMTS13 activity [33 (24-49)%] and high CRP level [23 (7.1-83.6) mg/L]. Adhesion of normal platelets showed a stepwise increase in the presence of cirrhotic plasmas, reaching the highest level in AD patients with ULMWM.
Characteristic changes of VWF parameters are seen in ST cirrhosis. In AD patients, highly increased VWF and reduced ADAMTS13 activity could be found, along with the presence of ULMWM, which are possible markers and contributors of the disease progression.
肝硬化患者体内的促凝和抗凝过程之间存在不稳定的平衡。我们假设,与稳定型肝硬化(ST)患者相比,急性失代偿(AD)患者中 von Willebrand 因子(VWF)的主要变化可能导致血栓形成倾向。
我们分析了 VWF 的不同参数,包括通过密度法分析详细的多聚体分布以及血小板黏附,同时分析整合素样金属蛋白酶与血栓调节素-1 结构域(ADAMTS13)活性和抗原以及 C 反应蛋白(CRP)水平,研究对象包括 ST 肝硬化患者( = 99)、AD 患者( = 54)和对照组( = 92)。
在两个肝硬化组中,VWF 抗原、瑞斯托霉素辅因子以及胶原结合活性呈逐步升高。大多数 ST 肝硬化患者的高分子量多聚体比例降低,低分子量多聚体比例升高。然而,在 54 例 AD 患者中有 24 例发现超大 VWF 多聚体(ultra-large molecular weight multimers [ULMWM])。在无 ULMWM 的 ST 和 AD 患者中,ADAMTS13 活性与对照组相似(中位数[四分位间距;IQR]%:98[67-132]和 91[60-110]与 106[88-117],分别)。AD 患者中存在 ULMWM 与 ADAMTS13 活性低[33(24-49)%]和 CRP 水平高[23(7.1-83.6)mg/L]相关。正常血小板黏附在存在肝硬化血浆时呈逐步升高,在存在 ULMWM 的 AD 患者中达到最高水平。
ST 肝硬化患者可见特征性的 VWF 参数变化。在 AD 患者中,可发现 VWF 显著增加和 ADAMTS13 活性降低,同时存在 ULMWM,这可能是疾病进展的标志物和促成因素。